Sanuwave Health (NASDAQ:SNWV) to Announce Q3 2025 Financial Results on November 7

EDEN PRAIRIE, Minn. — November 3, 2025 — Leads & Copy — Sanuwave Health, Inc. (NASDAQ: SNWV) will host a live conference call on Friday, November 7, 2025, at 8:30 AM (ET) to present its Q3 2025 financial results.

Telephone access to the call will be available by dialing Toll Free: 1-800-274-8461, Toll/International: 1-203-518-9814, Conference ID: SANUWAVE or click the link for instant telephone access to the event: https://viavid.webcasts.com/starthere.jsp?ei=1741017&tp_key=73ef3b515a. Materials for the conference call will be included on the Company’s website at www.sanuwave.com/investors. A replay will be made available through November 28, 2025 by dialing Toll-Free: 1-844-512-2921 or 1-412-317-6671, Replay Access ID: 11160405.

Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. Sanuwave’s end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.

Contact: investors@sanuwave.com

Source: Sanuwave Health, Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.